Pitavastatin is a novel statin that induces plaque regression and is non-inferior to atorvastatin ... on a 40 mg oral dose with the exception of fluvastatin extended release (80 mg) and ...

Cipla Ltd share price was up by 2.42% from the previous closing price of ₹1,436.80. Who are peers of Cipla Ltd? The peers of Cipla Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories ...

of patients were able to tolerate the EOD therapy (mean dose 5.6 mg) regimen for 4 ± 2.9 (mean ± SD) months. Mean LDL-C decreased 34.5% (p < 0.001) in the patients who tolerated the regimen ...

Shares of Cipla Ltd. fell as much as 2% on Monday after the Mumbai-based drug manufacturer informed the exchanges that its manufacturing facility in Bengaluru's Virgonagar has received a Voluntary ...

Cipla's stock is priced at Rs 1434.80, reflecting a percentage decrease of 0.99% today. The current 5-day exponential moving average (EMA5) is Rs 1480.29. Cipla is currently priced at Rs 1434.70, down ...

Cipla is currently trading at Rs 1470.55, reflecting a notable increase of 2.35% today, with 1-day returns at 2.03%. Cipla is currently valued at Rs 1466.00, marking a 2.04% rise today. The one-year ...

Cipla Ltd is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing developing and marketing wide range of branded and generic formulations and Active ...

Cipla Q3 Profit Surges 49% to Rs 1,571 Crore Cipla's net profit for Q3 FY25 jumped 49% to Rs 1,571 crore, driven by growth across markets. Revenue rose to Rs 7,073 crore. Read more. Jan 28, 2025 16:23 ...